North America

Tylenol-maker Kenvue’s stock has lost a quarter of its value in 6 months as momentum grows for autism link despite repeated denials
Kenvue rebuked claims of a connection between autism and acetaminophen and said it is “deeply concerned with the health risk this poses for expecting mothers.”